0001209191-16-126649.txt : 20160608
0001209191-16-126649.hdr.sgml : 20160608
20160608190236
ACCESSION NUMBER: 0001209191-16-126649
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160606
FILED AS OF DATE: 20160608
DATE AS OF CHANGE: 20160608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001396814
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510619477
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-254-3560
MAIL ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: PACIRA INC
DATE OF NAME CHANGE: 20080318
FORMER COMPANY:
FORMER CONFORMED NAME: Blue Acquisition Corp
DATE OF NAME CHANGE: 20070418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS PAUL J
CENTRAL INDEX KEY: 0001309702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35060
FILM NUMBER: 161704580
MAIL ADDRESS:
STREET 1: 61 HARTFORD STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-06
0
0001396814
Pacira Pharmaceuticals, Inc.
PCRX
0001309702
HASTINGS PAUL J
C/O PACIRA PHARMACEUTICALS, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY
NJ
07054
1
0
0
0
Common Stock
2016-06-06
4
S
0
1136
46.95
D
1717
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
/s/ James Scibetta, Attorney-in-Fact
2016-06-08